Skip to main content
Top
Published in: Infection 3/2018

01-06-2018 | Original Paper

Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study

Authors: Christoph D. Spinner, Christoph Boesecke, Cornelius Jordan, Christoph Wyen, Tim Kümmerle, Gaby Knecht, Stefan Scholten, Alexander Zink, Ivanka Krznaric, Sebastian Noe

Published in: Infection | Issue 3/2018

Login to get access

Abstract

Purpose

Sexually transmitted infections (STIs) occur frequently in risk populations. Hereby, the role of screening-programmes remains controversial. Our study aimed to determine the prevalence of STI infections in HIV-positive men-who-have-sex-with-men (MSM).

Methods

We enrolled asymptomatic, HIV-MSM in a prospective cross-sectional study from February to August 2016 at seven German HIV-centres. All subjects were screened for Treponema-pallidum (TP) and hepatitis-B/C-infection. HIV RNA and screening for oral, rectal and urethral colonisation by Chlamydia-trachomatis (CT) and/or Neisseria-gonorrhoeae (NG) was performed. All subjects were asked to complete a sexual-risk-behaviour-questionnaire.

Results

In total, 296 subjects with a median age of 43.2 (36.2–49.5) years were enrolled; 99.3% were on ART for 5.5 (2.3–11.2) years. HIV RNA was < 50 copies/mL in 93.6%. Active syphilis infection was found in 5.0% of all patients, whereas 55.4% had history of infection. HCV seropositivity was found in 33 patients (13.2%) and positive HCV RNA was available in 39.4%. 66/294 (22.5%) showed negative anti-HBs-antibodies, indicating lack of immunity. Overall, 40/296 (13.5%) had positive CT/NG swabs (CT in 8.8%; 7.3% anorectal, 1.7% oropharyngeal, 1.0% urethral and NG in 6.8%; 4.5% anal, 2.0% oropharyngeal, 1.4% urethral). Time since HIV infection < 7 years (OR 2.6 (1.2–5.5); p = 0.012), the use of inhalative nitrites (“poppers”) (OR 2.8 (1.3–5.9; p = 0.008) and reporting unprotected intercourse with > 20 partners within the last 6 months [OR 3.0 (1.2–7.8); p = 0.003] were significantly associated in multivariate analysis.

Conclusion

We found high numbers of asymptomatic syphilis, hepatitis-C and CT/NG infections in HIV-MSM, remarkably in patients with shorter duration of HIV-infection with more sexual partners within last 6 months.
Literature
1.
go back to reference Truong HM, Truong H-HM, Kellogg T, Klausner JD, Katz MH, Dilley J, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect. 2006;82:461–6.CrossRefPubMedPubMedCentral Truong HM, Truong H-HM, Kellogg T, Klausner JD, Katz MH, Dilley J, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect. 2006;82:461–6.CrossRefPubMedPubMedCentral
3.
go back to reference Braun DL, Marzel A, Steffens D, Schreiber PW, Grube C, Scherrer AU, et al. High rates of subsequent asymptomatic STIs and risky sexual behavior in patients initially presenting with primary HIV-1 infection. Clin. Infect. Dis. 2017. https://doi.org/10.1093/cid/cix873 Braun DL, Marzel A, Steffens D, Schreiber PW, Grube C, Scherrer AU, et al. High rates of subsequent asymptomatic STIs and risky sexual behavior in patients initially presenting with primary HIV-1 infection. Clin. Infect. Dis. 2017. https://​doi.​org/​10.​1093/​cid/​cix873
4.
go back to reference Grewal R, Allen VG, Gardner S, Moravan V, Tan DHS, Raboud J, et al. Serosorting and recreational drug use are risk factors for diagnosis of genital infection with chlamydia and gonorrhoea among HIV-positive men who have sex with men: results from a clinical cohort in Ontario, Canada. Sex Transm Infect. 2017;93:71–5.CrossRefPubMed Grewal R, Allen VG, Gardner S, Moravan V, Tan DHS, Raboud J, et al. Serosorting and recreational drug use are risk factors for diagnosis of genital infection with chlamydia and gonorrhoea among HIV-positive men who have sex with men: results from a clinical cohort in Ontario, Canada. Sex Transm Infect. 2017;93:71–5.CrossRefPubMed
6.
go back to reference Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, et al. Performance of the Cepheid CT/NG Xpert Rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013;51:1666–72.CrossRefPubMedPubMedCentral Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, et al. Performance of the Cepheid CT/NG Xpert Rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013;51:1666–72.CrossRefPubMedPubMedCentral
7.
go back to reference Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink H-J, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44:151–8 (Springer Berlin Heidelberg).CrossRefPubMed Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink H-J, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44:151–8 (Springer Berlin Heidelberg).CrossRefPubMed
9.
go back to reference Jansen K, Schmidt AJ, Drewes J, Bremer V, Marcus U. Increased incidence of syphilis in men who have sex with men and risk management strategies, Germany, 2015. Euro Surveill. European Centre for Disease. Prev Control. 2016;21:30382. Jansen K, Schmidt AJ, Drewes J, Bremer V, Marcus U. Increased incidence of syphilis in men who have sex with men and risk management strategies, Germany, 2015. Euro Surveill. European Centre for Disease. Prev Control. 2016;21:30382.
10.
go back to reference Jansen K, Thamm M, Bock C-T, Scheufele R, Kücherer C, Muenstermann D, et al. High prevalence and high incidence of coinfection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany. PLoS One. 2015;10:e0142515 (Margolis L, editor).CrossRefPubMedPubMedCentral Jansen K, Thamm M, Bock C-T, Scheufele R, Kücherer C, Muenstermann D, et al. High prevalence and high incidence of coinfection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany. PLoS One. 2015;10:e0142515 (Margolis L, editor).CrossRefPubMedPubMedCentral
11.
go back to reference Coll J, Videla S, Leon A, Ornelas A, García F, Fernández E, et al. Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with men. Infect: Clin Microbiol; 2017. Coll J, Videla S, Leon A, Ornelas A, García F, Fernández E, et al. Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with men. Infect: Clin Microbiol; 2017.
12.
go back to reference Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression source code biol med. BioMed Central. 2008;3:17. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression source code biol med. BioMed Central. 2008;3:17.
13.
go back to reference Wilson E, Free C, Morris TP, Syred J, Ahamed I, Menon-Johansson AS, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14:e1002479 (Broutet N, editor).CrossRefPubMedPubMedCentral Wilson E, Free C, Morris TP, Syred J, Ahamed I, Menon-Johansson AS, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14:e1002479 (Broutet N, editor).CrossRefPubMedPubMedCentral
14.
go back to reference Tideman RL, Pitts MK, Fairley CK. Effects of a change from an appointment service to a walk-in triage service at a sexual health centre. Int J STD AIDS. 2003;14:793–5.CrossRefPubMed Tideman RL, Pitts MK, Fairley CK. Effects of a change from an appointment service to a walk-in triage service at a sexual health centre. Int J STD AIDS. 2003;14:793–5.CrossRefPubMed
15.
go back to reference Nguyen V-K, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study. AIDS. 2017;1 Nguyen V-K, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study. AIDS. 2017;1
16.
go back to reference Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, et al. Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65:712–8.CrossRefPubMedPubMedCentral Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, et al. Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65:712–8.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study
Authors
Christoph D. Spinner
Christoph Boesecke
Cornelius Jordan
Christoph Wyen
Tim Kümmerle
Gaby Knecht
Stefan Scholten
Alexander Zink
Ivanka Krznaric
Sebastian Noe
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1124-6

Other articles of this Issue 3/2018

Infection 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.